Saxonov Serge's Form 4 filing
10x Genomics, Inc. (TXG) · filed Nov 25, 2024
- Accession no.
- 0001610717-24-000530
- Filed
- Nov 25, 2024
- Trade date
- Nov 21-22, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $91.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saxonov SergeCIK 0001786720 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Class A Common Stock | GGiftDisposed | −1,850 | $0.00 | $0 | 879,267 | Direct | |
| Nov 22, 2024 | Class A Common Stock | SSaleDisposed | −6,693 | $13.69 | −$91,627.17 | 872,574 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.